CSI Market
Sign In | Register

Caredx Inc (CDNA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CDNA quarterly Cash Flow →
From Caredx Inc through Dec 31 2021, changes in Dec 31 2025's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-21.35
Depreciation & amortization15.02
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges2.96
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-4.96
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.05
Share-based Compensation34.86
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Amortization Of Deferred Charges-
Amortization Of Deferred Revenue-
Accretion Of Discount-
Cost Of Goods And Services Sold Depreciation-
Loss On Conversion Of Debt To Equity-
Operating Lease Expense-
Loss On Write Off Of Fixed Assets-
Finance Lease Right Of Use Asset Amortization-
Investment Income Amortization Of Premium-
Marketable Securities Unrealized Gain Loss-
Investment Income Net Amortization Of Discount And Premium-
Increase Decrease In Operating Lease Liabilities5.40
Equity Securities Fv Ni Realized Gain-
Income taxes0.00
Gain (Loss) on Investments0.00
Increase (Decrease) in Accounts Receivable22.52
Increase (Decrease) in Accounts Payable, Trade0.81
Accrued Expense-4.15
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other-4.40
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-4.72
Discontinued operations0.00
Net Cash flow from Operating Activities42.03
Investing Activities
Capital Expenditures-0.68
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities154.67
Payments to Acquire Marketable Securities-145.93
Real Estate Investments0.00
Payments To Acquire Businesses And Noncontrolling Interest-
Payments To Acquire Capital Expenditures Net-5.91
Payments To Acquire Short Term Marketable Securities-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities2.16
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-79.77
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-130.04
Proceeds From Issuance Of Common Stock Net Of Issuance Cost-
Proceeds From Issuance Of Common Stock Net Of Issuance Costs-
Proceeds From Private Placement And Subsequent Financing Net Of Issuance Costs-
Payments To Acquire Businesses Related To Financing Activity-
Taxes Paid Related To Net Share Settlement Of Restricted Stock Units-
Restricted Cash And Cash Equivalents Noncurrent-
Restricted Cash And Cash Equivalents-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents115.27
Debt Conversion Converted Instrument Amount-
Offering Costs-
Employee Stock Purchase Plan Shares1.14
Debt Conversion Converted Instrument Common Stock Warrants Issued-
Common Stock Shares Issued For Contingent Consideration-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-93.39
Effect of exchange rate on cash flow-0.09
Discontinued operations0.00
Free Cash Flow41.36
Total Cash Flow-49.29
4 historic quarters locked

Sign in to unlock the full Caredx Inc cash flow history.

Sign In Create Free Account

About Caredx Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: cdna-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001217234-26-000018

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License